KCNK6 Antibody
-
中文名称:KCNK6兔多克隆抗体
-
货号:CSB-PA080005
-
规格:¥880
-
其他:
产品详情
-
Uniprot No.:Q9Y257
-
基因名:KCNK6
-
别名:KCNK6; TOSS; TWIK2; Potassium channel subfamily K member 6; Inward rectifying potassium channel protein TWIK-2; TWIK-originated similarity sequence
-
宿主:Rabbit
-
反应种属:Human
-
免疫原:Synthesized peptide derived from the C-terminal region of Human TWIK-2.
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
-
抗体亚型:IgG
-
纯化方式:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
-
产品提供形式:Liquid
-
应用范围:WB, ELISA
-
推荐稀释比:
Application Recommended Dilution WB 1:500-1:2000 ELISA 1:5000 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:Exhibits outward rectification in a physiological K(+) gradient and mild inward rectification in symmetrical K(+) conditions.
-
基因功能参考文献:
- Identification and characterization of Kcnk6 expression within the mammalian cochlea established the gene as a functional candidate for DFNA4. PMID: 14689445
-
亚细胞定位:Membrane; Multi-pass membrane protein.
-
蛋白家族:Two pore domain potassium channel (TC 1.A.1.8) family
-
组织特异性:Widespread expression, detected in all tissues tested except for skeletal muscle. Strongest expression in placenta, pancreas, heart, colon and spleen, lower levels detected in peripheral blood leukocytes, lung, liver, kidney and thymus. Lowest expression
-
数据库链接:
HGNC: 6281
OMIM: 603939
KEGG: hsa:9424
STRING: 9606.ENSP00000263372
UniGene: Hs.240395
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IF, FC
Species Reactivity: Human, Mouse, Rat
-
-
-
-
-
-